Apyx Medical Corp expected to post a loss of 12 cents a share - Earnings Preview

Apyx Medical

06/05/2025 13:52

Apyx Medical Corp APYX.OQ APYX.O is expected to show a fall in quarterly revenue when it reports  results on May 8 for the period ending March 31 2025

The Clearwater Florida-based  company is expected to report a 8.4% decrease in revenue to $9.388 million from $10.24 million a year ago, according to the mean estimate from 3 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Apyx Medical Corp is for a loss of 12 cents per share.

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Apyx Medical Corp is $4.00​, above​ its last closing price of $1.16. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.17
-0.16
-0.12
Beat
25
Sep. 30 2024
-0.19
-0.19
-0.14
Beat
24.6
Jun. 30 2024
-0.20
-0.20
-0.19
Beat
4.1​
Mar. 31 2024
-0.22
-0.21
-0.22
Missed
-2.6
​​Dec. 31 2023
-0.20
-0.18
-0.28
Missed
-57.7
Sep. 30 2023
-0.12
-0.11
-0.13
Missed
-14.8​
Jun. 30 2023
-0.07
-0.07
-0.11
Missed
-58.5
Mar. 31 2023
-0.16
-0.13
-0.10
Beat
25.9

This summary was machine generated May 6 at 12:52 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)